This is the authors' abstract. We don't add key points for this paper.
The human papillomavirus (HPV) vaccine is regarded as one of the most effective ways of preventing cervical cancer. Despite the massive burden of this disease, only two countries in the Eastern Mediterranean Region (EMR) have implemented a national HPV vaccination program. The aim of the present study was to assess the main barriers to the integration of HPV vaccination in the national vaccination programs of EMR countries.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Hakimi et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: